Nifty Outlook for July 14: Support levels held by analysts advice caution near 24,300 supply zone

Nifty Outlook for July 14: Support levels held by analysts advice caution near 24,300 supply zone

The Nifty 50 extended its winning streak to a third consecutive session on Monday, ending 4 points higher at 24,211 after recovering sharply from early losses. The index opened 168 points lower amid concerns over escalating geopolitical tensions in West Asia. However, buying emerged near the 24,000 mark, helping the benchmark rebound more than 250…

Read More
HCLTech to invest up to ₹3,500 crore in AI data centres, enters full-stack AI market

HCLTech to invest up to ₹3,500 crore in AI data centres, enters full-stack AI market

HCLTechwill invest up to ₹3,500 crore to establish AI data centres in India as it enters the full-stack AI market, seeking to tap rising demand for artificial intelligence-led services from enterprises and government customers. The investment will be made through newly incorporated wholly owned subsidiaries and has the potential to scale up to 50MW of…

Read More
HCL Tech Dividend: Rs 12 cash reward announced in Q1 FY27 - Check record date, payment date - Markets

HCL Tech Dividend: Rs 12 cash reward announced in Q1 FY27 – Check record date, payment date – Markets

Sarmeeli Mallick is a senior journalist with nearly a decade of experience in digital journalism. With a master’s degree in Journalism and Mass Communication from Utkal University, Bhubaneswar, she has a proven track record of impactful reporting, having filed over 19,000 news stories since beginning her career in May 2016. Her diverse background, rooted in…

Read More
Emcure to make Gennova Biopharma wholly owned subsidiary with ₹232 crore stake buyout

Emcure to make Gennova Biopharma wholly owned subsidiary with ₹232 crore stake buyout

Emcure Pharmaceuticals Ltd announced on Monday, July 13, that it will acquire the remaining 12.05% stake in its subsidiary Gennova Biopharmaceuticals Ltd for ₹231.87 crore, making the biotechnology company a wholly-owned subsidiary. In an exchange filing, the pharma company said it has signed share transfer agreements with all individual shareholders of Gennova to acquire 663,865…

Read More